Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
To elucidate the pathological roles of system L amino acid transporter LAT1 in tumor microenvironment, we examined in vitro endothelial function and in vivo tumor angiogenesis using LAT1 selective inhibitor, JPH203. JPH203 elicited amino acid deprivation stress and impaired endothelial cell growth, migration and tube formation in human umbilical vein endothelial cells. In mouse B16F10 melanoma xenograft model, JPH203 significantly inhibited tumor growth by attenuating angiogenesis. Taken together, these findings have provided the new insight in LAT1 function in tumor progression and showed the possibility of JPH203 as an angiogenesis inhibitor.
|